Comparison of the Efficacy and Safety of AtorVastatin mOnotherapy vs. Combination Atorvastatin/Fenofibric Acid
Status:
Unknown status
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare combination atorvastatin/fenofibric acid 10/135mg
with atorvastatin 20mg monotherapy in the mixed hyperlipidemia who were not at lipid goals
with atorvastatin 10mg monotherapy.